CLL Updates and the Venetoclax Story With Matt Davids

Jan 7, 2025

Chadi speaks with Dr. Matt Davids, a hematology expert at Dana-Farber Cancer Institute and Harvard Medical School, known for his groundbreaking work on CLL therapies. They delve into the latest advancements in CLL treatment, highlighting the development of venetoclax. Dr. Davids shares his personal experiences from pivotal conferences and the excitement surrounding the drug's efficacy. The conversation also explores innovations in drug mechanisms and promising combination therapies that could redefine treatment paradigms for blood cancers.

Ask episode

Chapters

Books

Transcript

Episode notes

Intro

00:00 • 4min

Journey of a Clinician-Scientist in CLL

04:18 • 12min

First Presentation Excitement and Reflections on Venetoclax

16:08 • 2min

Advancements in BCL2 Inhibitors

17:56 • 7min

Exploring Drug Mechanisms in Cancer Treatment

24:32 • 2min

Innovations in CLL Treatment

26:04 • 19min